Clinical trials
Phase 2 Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
721 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 8 |
| 2001 | 12 |
| 2002 | 25 |
| 2003 | 19 |
| 2004 | 24 |
| 2005 | 48 |
| 2006 | 53 |
| 2007 | 35 |
| 2008 | 28 |
| 2009 | 35 |
| 2010 | 30 |
| 2011 | 27 |
| 2012 | 26 |
| 2013 | 15 |
| 2014 | 26 |
| 2015 | 24 |
| 2016 | 26 |
| 2017 | 17 |
| 2018 | 26 |
| 2019 | 32 |
| 2020 | 18 |
| 2021 | 27 |
| 2022 | 28 |
| 2023 | 18 |
| 2024 | 17 |
| 2025 | 28 |
| 2026 | 19 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 401 |
| Terminated | 145 |
| Recruiting | 70 |
| Active, not recruiting | 50 |
| Withdrawn | 24 |
| Unknown status | 20 |
| Not yet recruiting | 8 |
| Suspended | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 45 |
| M.D. Anderson Cancer Center | 30 |
| AbbVie | 19 |
| Novartis Pharmaceuticals | 19 |
| Eli Lilly and Company | 18 |
| GlaxoSmithKline | 17 |
| Memorial Sloan Kettering Cancer Center | 17 |
| Bayer | 9 |
| University of Utah | 9 |
| Merck Sharp & Dohme LLC | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 721 |
| Neoplasm Metastasis | 99 |
| Breast Neoplasms | 53 |
| Carcinoma, Non-Small-Cell Lung | 50 |
| Recurrence | 43 |
| Carcinoma | 39 |
| Prostatic Neoplasms | 38 |
| Pancreatic Neoplasms | 36 |
| Colorectal Neoplasms | 34 |
| Ovarian Neoplasms | 33 |
Trials
Showing 1 to 25 of 721. Each trial links to its page on Pharma Observatory.
621 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.